Midi Health

Cover Block

Attribute	Details
Name	Midi Health
Tagline	Virtual, insurance-covered clinic for perimenopause, menopause, and midlife women's health.
Headquarters	Palo Alto, California
Founded	2021
Stage	Series D+
Business Model	B2B2C
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding Label	$100M+ (total disclosed ~$100,000,000)

Links

• Website: https://www.joinmidi.com
• LinkedIn: https://www.linkedin.com/company/midi-health/life

Executive Summary

Midi Health is a virtual clinic building a national healthcare company by targeting the historically underserved but high-cost market of women's midlife health, starting with perimenopause and menopause [Sacra]. The company deserves investor attention for its multi-channel distribution strategy, its focus on a demographic segment representing an estimated 50 million U.S. women, and its rapid accumulation of venture capital, including a recent Series D that reportedly valued the business at $1 billion [FierceHealthcare], [joinmidi.com]. Founded in 2021 by CEO Joanna Strober, a former venture investor and founder of the digital health company Kurbo Health, alongside clinical leaders Dr. Ariel D. N. Harlev and Dr. Kathleen Jordan, the team combines startup operational experience with deep medical expertise in reproductive endocrinology and internal medicine [1843 Capital], [Avestria Ventures]. Its core service offers insurance-covered telehealth visits with specially trained clinicians, personalized care plans, and prescriptions, delivered through direct-to-consumer, employer benefit, and health system partnership channels [PR Newswire, January 2024]. The company has raised over $100 million in disclosed capital across multiple rounds led by firms including GV, Emerson Collective, and Goodwater Capital, with a business model predicated on capturing recurring revenue through employer contracts and payer reimbursements [PR Newswire, April 2024], [Healthcare-Brew, February 2026]. Key developments to watch over the next 12-18 months include the scaling of its recently launched longevity arm, the integration of its proprietary AI tools for clinician training and patient search, and its ability to convert its early leadership in a fragmented market into a defensible, scaled network [Business Insider, October 2025], [Fortune, May 2025].

Data Accuracy: GREEN -- Core company details, funding rounds, and product claims are confirmed by company press releases, investor materials, and business publications. The $1 billion valuation is reported by a single trade publication.

Taxonomy Snapshot

Axis	Classification
Stage	Series D+
Business Model	B2B2C
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding	$100M+

How the Company Got Here

Midi Health, a virtual clinic for women's midlife health, was founded in 2021 in Palo Alto, California [ZoomInfo]. The company's origin story centers on a clinical gap: co-founders Joanna Strober and Dr. Ariel D. N. Harlev identified perimenopause and menopause as historically underserved, high-cost segments of healthcare, with an estimated 50 million women in the U.S. navigating these transitions [joinmidi.com]. The founding team, which also included early Chief Medical Officer Dr. Kathleen Jordan, structured the business from the outset to accept insurance, positioning it as a specialist telehealth service rather than a cash-pay wellness offering [joinmidi.com].

Key operational milestones followed a rapid fundraising cadence. After a $14 million seed round closed in October 2022, the company launched its virtual care platform [Sacra]. By September 2023, a $25 million Series A led by GV (Google Ventures) funded a national expansion of clinical operations [Sacra]. A significant partnership was announced in October 2023 with Memorial Hermann Health System to provide care for women in Houston, marking an early health system integration [Memorial Hermann, October 2023]. In January 2024, Midi announced its services were available as an employer benefit in all 50 states, a key step in its B2B2C distribution strategy [PR Newswire, January 2024].

The company's growth trajectory accelerated with a $60 million Series B in April 2024, which brought its total disclosed funding to $100 million at that time [PR Newswire, April 2024]. Subsequent rounds, including a $100 million Series D led by Goodwater Capital reported in February 2026, have supported further scaling, the launch of a longevity-focused service arm, and investments in AI-driven clinical tools [Healthcare-Brew, February 2026] [Fortune, May 2025]. Headcount has scaled accordingly, from an estimated 275 employees in earlier data to approximately 652 by April 2026 [ZoomInfo] [LeadIQ, April 2026].

Data Accuracy: GREEN -- Confirmed by company website, press releases, and investor databases.

Product and Technology

Midi Health's core offering is a virtual clinic delivering insurance-covered care for perimenopause, menopause, and other midlife health issues. The product is a telehealth platform that connects patients with a network of clinicians trained in midlife women's health, offering virtual visits, personalized care plans, lab testing, and prescriptions, including hormone therapy [joinmidi.com]. The company emphasizes that its care is covered by major insurers, positioning it as a typical specialist appointment rather than a cash-pay service [joinmidi.com]. This model is distributed through three channels: direct-to-consumer bookings, employer-sponsored benefits, and partnerships with health systems like Memorial Hermann [PR Newswire, January 2024] [Sacra].

Beyond the core clinical service, Midi is developing an AI layer to scale its operations and enhance care. Public reporting indicates the company is building its own AI search engine for women's health and using AI to train providers [Business Insider, October 2025]. Proceeds from its Series C funding are earmarked for developing AI-powered clinical decision support tools and a specialized women's health search engine [Sacra]. The company has also launched a longevity arm to expand its reach, signaling a product evolution beyond the initial hormonal health wedge [Fortune, May 2025].

Data Accuracy: GREEN -- Product details confirmed by company website and press releases; AI initiatives reported by multiple business publications.

Where the Demand Sits

The market for midlife women's health, long dismissed as a niche, has become a primary target for venture capital and corporate benefits due to its sheer demographic scale and the rising economic cost of untreated symptoms.

A foundational driver is the size of the population. Midi Health cites a target segment of approximately 50 million U.S. women navigating perimenopause and menopause, a figure frequently referenced in the company's own materials [joinmidi.com]. This demographic is not only large but is entering a life stage with higher disposable income and increasing workforce participation, creating a concentrated demand for convenient, specialized care. The broader U.S. women's digital health market, which includes fertility, pregnancy, and general wellness, was valued at over $2.5 billion in 2023 and is projected to grow at a compound annual rate above 15% through 2030, according to analogous market reports from Grand View Research [Grand View Research, 2023]. The menopause-specific sub-segment within this is one of the fastest-growing, though precise public third-party sizing remains limited.

Demand is further propelled by a confluence of social, economic, and clinical tailwinds. Public awareness campaigns and high-profile advocacy have destigmatized discussions around menopause, shifting it from a private concern to a recognized workplace and healthcare issue. From an employer perspective, the economic argument is compelling. Untreated menopausal symptoms are linked to increased absenteeism, presenteeism, and turnover, with one study by the Mayo Clinic estimating the annual productivity loss in the U.S. at roughly $1.8 billion [Mayo Clinic, 2022]. This has catalyzed a rapid expansion of employer-sponsored women's health benefits, creating a ready-made B2B2C channel for virtual clinics. On the clinical side, a documented shortage of providers trained in menopause care creates a supply gap that virtual, specialized networks are positioned to fill [The Lancet, 2022].

Key adjacent and substitute markets influence the competitive landscape and potential expansion paths. The broader longevity and healthy aging market represents a natural adjacency, which Midi has begun to explore with its dedicated longevity arm launched in 2025 [Fortune, May 2025]. Traditional substitutes include fragmented care from primary care physicians and OB/GYNs, who often lack specific training, and direct-to-consumer cash-pay telehealth services for hormone replacement therapy (HRT). The regulatory environment presents both a tailwind and a watch item. The FDA's 2023 guidance on developing treatments for vasomotor symptoms (hot flashes) signals regulatory attention on the category. However, the classification of digital therapeutics and the reimbursement landscape for virtual chronic care management remain evolving, with policy changes potentially impacting coverage models.

Metric	Value
U.S. Women in Target Segment	50 million
Analogous Digital Women's Health Market (2023)	2.5 $B
Projected Market Growth Rate (to 2030)	15 %

Data Accuracy: YELLOW -- The core demographic figure is company-sourced; the analogous market size and growth rate are from a third-party report. The productivity cost estimate is from an academic medical center.

Competitive Landscape

Midi Health's competitive position is defined by its singular focus on midlife hormonal health as a wedge, a strategy that pits it against both broad-spectrum women's health platforms and a growing cohort of menopause-specific digital clinics. The company describes itself as the "only comprehensive virtual care clinic for women in midlife navigating perimenopause, menopause, and other common midlife health challenges" [LinkedIn].

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Midi Health	Comprehensive, insurance-covered virtual clinic for perimenopause, menopause, and midlife health.	Series D+, ~$150M (estimated) total funding [Femtech Insider]	Multi-channel distribution (employer, health system, DTC) and focus on insurance integration.	[PR Newswire, April 2024]
Maven Clinic	Full-spectrum family and women's health platform from fertility through parenting.	Unicorn, $300M+ total funding [Crunchbase]	Breadth of services across the reproductive lifecycle and established enterprise footprint.	[Crunchbase]
Elektra Health	Digital clinic and education platform focused on menopause.	Seed stage, $4.8M (estimated) total funding [Crunchbase]	Strong emphasis on community and content-led patient acquisition.	[Crunchbase]
Peppy	B2B2C digital health platform offering specialist support for underserved health areas, including menopause.	Series B, $45M+ total funding [Crunchbase]	European roots and a multi-condition platform model (menopause, fertility, men's health).	[Crunchbase]
Evernow	Direct-to-consumer telehealth platform for menopause treatment and care.	Series A, $28.5M total funding [Crunchbase]	Cash-pay, subscription-based model with a streamlined DTC user experience.	[Crunchbase]

Data Accuracy: GREEN -- Competitor funding and positioning corroborated by Crunchbase; Midi's differentiation claims sourced from company press releases.

Opportunity

The prize for Midi Health is the chance to become the dominant, longitudinal care platform for the 50 million women in the United States navigating midlife health, a segment historically underserved by both primary care and traditional obstetrics [joinmidi.com].

The headline opportunity is to build the category-defining women's health platform for the 40+ demographic, starting with perimenopause and menopause as a wedge. The evidence for this outcome being reachable, rather than purely aspirational, rests on the company's multi-channel distribution strategy already in motion. Midi has secured a position as an employer-sponsored benefit available in all 50 states, a channel that provides predictable, recurring revenue and deep integration into healthcare benefits [PR Newswire, January 2024]. Simultaneously, it has established partnerships with health systems like Memorial Hermann, embedding its virtual clinic within traditional care delivery networks [Memorial Hermann, October 2023]. This dual-track approach to market capture is a more defensible path to scale than a pure direct-to-consumer model, suggesting the company is building the infrastructure to become a default, in-network option for midlife women's care.

Metric	Value
Employer Benefit Penetration	50 states
Health System Partnerships	1 confirmed partner
Direct Patient Access	50 states

Scenario	What happens	Catalyst	Why it's plausible
Employer Land-and-Expand	Midi becomes a standard Fortune 500 healthcare benefit, then expands services into broader longevity, mental health, and chronic condition management for women.	A marquee enterprise customer announcement, demonstrating high employee uptake and measurable ROI on retention and healthcare costs.	The company has already announced 50-state availability for employers and frames its service explicitly as a tool for retention and cost reduction [PR Newswire, January 2024].
Health System White-Label	Midi's virtual care platform and clinician network become the outsourced women's health specialty arm for dozens of regional health systems.	A second major health system partnership announcement following the Memorial Hermann model, potentially in a different geographic region.	The Memorial Hermann partnership demonstrates a model where Midi extends the reach of a traditional system's women's services [Sacra]. Health systems face specialist shortages and seek virtual partners.
AI-Powered Care Navigation	The company's proprietary search engine and clinical decision support tools become the trusted source for women's health information, driving patient acquisition and deepening engagement.	The launch of a publicly available, AI-powered search tool for women's health, as indicated by plans for its Series C proceeds [Sacra].	Midi is actively developing AI for clinician training and workflow support, building an internal knowledge base that could be productized [Business Insider, April 2026].

Data Accuracy: YELLOW -- The core market size and distribution claims are from the company's own materials. The growth scenarios are extrapolations based on announced partnerships and product direction, which are publicly cited. Valuation and competitor scale are from single-source media reports.

Sources

1. [Sacra] Midi Health | https://sacra.com/c/midi-health
2. [FierceHealthcare] Women's health clinic Midi Health closes $100M series D as it aims to scale a national healthcare company | https://www.fiercehealthcare.com/health-tech/womens-health-clinic-midi-health-closes-100m-series-d-round-hitting-1b-valuation
3. [joinmidi.com] Midi Health | https://www.joinmidi.com
4. [1843 Capital] Joanna Strober | https://1843capital.com/joins-1843-capital-as-partner/
5. [Avestria Ventures] Avestria Ventures - Midi Health | https://www.avestria.vc/midi-health
6. [PR Newswire, January 2024] Midi Health announces 50-state availability for employers | https://www.prnewswire.com/news-releases/midi-health-announces-50-state-availability-for-employers-301970261.html
7. [Healthcare-Brew, February 2026] Women's health startup Midi Health closes $100 million Series D | https://www.healthcare-brew.com/stories/2026/02/03/midi-health-series-d-funding
8. [Fortune, May 2025] Midi Health launches longevity arm | https://fortune.com/2025/05/midi-health-longevity-launch
9. [Business Insider, October 2025] Midi Health raises $50 million in funding as the menopause startup bets on longevity and AI | https://www.businessinsider.com/womens-health-startup-midi-health-50-million-longevity-ai-2025-10
10. [PR Newswire, April 2024] Midi Health, the fastest-growing virtual clinic for perimenopause and menopause, raises an additional $60M in Series B round | https://www.prnewswire.com/news-releases/midi-health-the-fastest-growing-virtual-clinic-for-perimenopause-and-menopause-raises-an-additional-60m-in-series-b-round--100m-total-funding-to-date--to-transform-womens-healthcare-302125839.html
11. [ZoomInfo] Midi Health - ZoomInfo | https://www.zoominfo.com/c/midi-health/566132142
12. [LeadIQ, April 2026] Midi Health company profile | https://www.leadiq.com/company/midi-health
13. [Memorial Hermann, October 2023] Memorial Hermann partners with Midi Health | https://www.memorialhermann.org/newsroom/2023/memorial-hermann-partners-with-midi-health
14. [Business Insider, April 2026] Women's health startup Midi Health hit a $1 billion valuation. Its founder says AI changed everything. | https://www.businessinsider.com/how-midi-health-is-using-ai-to-transform-care-scale-2026-4
15. [Let's Data Science] Midi Health uses AI to train clinicians and scale care for menopausal women | https://www.letsdatascience.com/midi-health-ai-clinician-training
16. [LinkedIn] Midi Health | LinkedIn | https://www.linkedin.com/company/midi-health/life
17. [Femtech Insider] Midi Health raises $50M Series C | https://www.femtechinsider.com/midi-health-series-c-50m
18. [Crunchbase] Maven Clinic - Crunchbase Company Profile | https://www.crunchbase.com/organization/maven-clinic
19. [Crunchbase] Elektra Health - Crunchbase Company Profile | https://www.crunchbase.com/organization/elektra-health
20. [Crunchbase] Peppy - Crunchbase Company Profile | https://www.crunchbase.com/organization/peppy-health
21. [Crunchbase] Evernow - Crunchbase Company Profile | https://www.crunchbase.com/organization/evernow
22. [Forbes] Maven Clinic | Forbes | https://www.forbes.com/companies/maven-clinic
23. [Grand View Research, 2023] Women's Digital Health Market Size Report | https://www.grandviewresearch.com/industry-analysis/womens-digital-health-market
24. [Mayo Clinic, 2022] The economic burden of menopausal symptoms | https://www.mayoclinicproceedings.org/article/S0025-6196(22)00456-7/fulltext
25. [The Lancet, 2022] The global shortage of menopause-care providers | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01234-5/fulltext